Perspectives on carbon nanotube-mediated adverse immune effects.

Carbon nanotubes are entities of different morphology and aspect ratios with anisotropic character. Due to their unique electronic, photonic, mechanical and chemical properties, carbon nanotubes are receiving increasing attention in nanomedicine research where examples include site-specific drug and nucleic acid delivery, photodynamic therapy and photoacoustic molecular imaging. The interaction of carbon nanotubes with the immune system, which plays a key role in the recognition and elimination of foreign materials, and consequential responses, is of central importance for the proposed successful biomedical applications of nanotubes. Research in this avenue, however, is scant and the limited available data are rather contradictory. In this progress article we have collected some of the most important experimental results obtained thus far on carbon nanotube-mediated immune toxicity with an emphasis on cardiovascular exposure, including activation of the complement system, macrophage recognition and clearance, and overall effects on the functionality of different immune cells. Mapping these immune-related risks as well as understanding their molecular mechanisms is a crucial step in the development of any carbon nanotube-containing nanopharmaceuticals.

[1]  Malcolm L. H. Green,et al.  Complement activation and protein adsorption by carbon nanotubes. , 2006, Molecular immunology.

[2]  John D Lambris,et al.  Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.

[3]  Chen Wang,et al.  Carbon Nanotubes Enhance Cytotoxicity Mediated by Human Lymphocytes In Vitro , 2011, PloS one.

[4]  Francisco Pompeo,et al.  Water Solubilization of Single-Walled Carbon Nanotubes by Functionalization with Glucosamine , 2002 .

[5]  S. Moghimi,et al.  Complement monitoring of carbon nanotubes. , 2010, Nature nanotechnology.

[6]  Maurizio Prato,et al.  CELL-PENETRATING CNTS FOR DELIVERY OF THERAPEUTICS , 2007 .

[7]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[8]  M. Zheng,et al.  DNA-assisted dispersion and separation of carbon nanotubes , 2003, Nature materials.

[9]  Haifang Wang,et al.  Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. , 2008, Toxicology letters.

[10]  R. Krishnamoorti,et al.  Small-angle neutron scattering from surfactant-assisted aqueous dispersions of carbon nanotubes. , 2004, Journal of the American Chemical Society.

[11]  Miklós Tóth,et al.  Animal Models of Complement-Mediated Hypersensitivity Reactions to Liposomes and Other Lipid-Based Nanoparticles , 2007, Journal of liposome research.

[12]  H. Dai,et al.  In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.

[13]  Dan Peer,et al.  Reshaping the future of nanopharmaceuticals: ad iudicium. , 2011, ACS nano.

[14]  M. Prato,et al.  Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. , 2006, Nano letters.

[15]  John D Lambris,et al.  Molecular Intercommunication between the Complement and Coagulation Systems , 2010, The Journal of Immunology.

[16]  M. Prato,et al.  Organic functionalization of carbon nanotubes. , 2002, Journal of the American Chemical Society.

[17]  Q. Gong,et al.  Single-wall carbon nanotube colloids in polar solvents , 2000 .

[18]  S W Burchiel,et al.  Mechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in mice. , 2009, Nature nanotechnology.

[19]  Eva Pebay-Peyroula,et al.  Proteins of the innate immune system crystallize on carbon nanotubes but are not activated. , 2011, ACS nano.

[20]  Weibo Cai,et al.  Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.

[21]  L. Pylkkänen,et al.  Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells. , 2010, Toxicology.

[22]  Bo Zhang,et al.  Carbon nanotubes in cancer diagnosis and therapy. , 2010, Biochimica et biophysica acta.

[23]  S Moein Moghimi,et al.  Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. , 2010, ACS nano.

[24]  Robert B Sim,et al.  Effect of functionalization of carbon nanotubes with psychosine on complement activation and protein adsorption. , 2011, Journal of biomedical nanotechnology.

[25]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[26]  M. Prato,et al.  Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing , 2011, Proceedings of the National Academy of Sciences.

[27]  Xin Chen,et al.  BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25− responder T cells than C57BL/6 mice , 2005, Journal of leukocyte biology.

[28]  G. Keskar,et al.  Single-molecule fluorescence microscopy and Raman spectroscopy studies of RNA bound carbon nanotubes , 2004 .

[29]  Guibin Jiang,et al.  Steering carbon nanotubes to scavenger receptor recognition by nanotube surface chemistry modification partially alleviates NFκB activation and reduces its immunotoxicity. , 2011, ACS nano.

[30]  S. Moghimi,et al.  Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process. , 2008, Molecular immunology.

[31]  S. Moghimi,et al.  Complement system and the brain: selected pathologies and avenues toward engineering of neurological nanomedicines. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Maurizio Prato,et al.  Carbon-nanotube shape and individualization critical for renal excretion. , 2008, Small.

[33]  Haiqing Peng,et al.  Sidewall carboxylic acid functionalization of single-walled carbon nanotubes. , 2003, Journal of the American Chemical Society.

[34]  M. Prato,et al.  Applications of carbon nanotubes in drug delivery. , 2005, Current opinion in chemical biology.

[35]  H. Dai,et al.  Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. , 2008, Molecular immunology.

[36]  M. Prato,et al.  Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. , 2007, Nature nanotechnology.

[37]  Z. Gu,et al.  Biodistribution of carbon single-wall carbon nanotubes in mice. , 2004, Journal of nanoscience and nanotechnology.

[38]  P. Ajayan.  Nanotubes from Carbon. , 1999, Chemical reviews.

[39]  Nunzio Bottini,et al.  PEG-modified carbon nanotubes in biomedicine: current status and challenges ahead. , 2011, Biomacromolecules.

[40]  A. Matsukawa,et al.  INNATE IMMUNE RESPONSE IN TH1- AND TH2-DOMINANT MOUSE STRAINS , 2004, Shock.

[41]  J Szebeni,et al.  Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[42]  Magnus Bergkvist,et al.  Paradoxical glomerular filtration of carbon nanotubes , 2010, Proceedings of the National Academy of Sciences.

[43]  Zhuang Liu,et al.  Carbon nanotubes as photoacoustic molecular imaging agents in living mice. , 2008, Nature nanotechnology.

[44]  M. Dresselhaus,et al.  Electronic, thermal and mechanical properties of carbon nanotubes , 2004, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.

[45]  Roberto Madeddu,et al.  Ex vivo impact of functionalized carbon nanotubes on human immune cells. , 2012, Nanomedicine.

[46]  Xin Wang,et al.  Biodistribution of Pristine Single-Walled Carbon Nanotubes In Vivo† , 2007 .

[47]  S. Iijima.  Helical microtubules of graphitic carbon , 1991, Nature.

[48]  Luca Costantino,et al.  Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. , 2012, Nanomedicine.

[49]  Davoud Ahmadvand,et al.  Material properties in complement activation. , 2011, Advanced drug delivery reviews.

[50]  M. Prato,et al.  Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Sanjiv S Gambhir,et al.  A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. , 2008, Nature nanotechnology.

[52]  A. Weintraub,et al.  Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2 , 2006 .

[53]  Zhuang Liu,et al.  Carbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathway. , 2006, Angewandte Chemie.

[54]  G. Winkler.  Pulmonary intravascular macrophages in domestic animal species: review of structural and functional properties. , 1988, The American journal of anatomy.

[55]  S M Moghimi,et al.  Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. , 2012, Annual review of pharmacology and toxicology.

[56]  M. Foldvari,et al.  Carbon nanotubes as functional excipients for nanomedicines: I. Pharmaceutical properties. , 2008, Nanomedicine : nanotechnology, biology, and medicine.

[57]  Akihiko Hirose,et al.  Effects of sustained stimulation with multi-wall carbon nanotubes on immune and inflammatory responses in mice. , 2012, The Journal of toxicological sciences.

[58]  Howard Wang,et al.  Dispersing Single-Walled Carbon Nanotubes with Surfactants: A Small Angle Neutron Scattering Study , 2004 .

[59]  M. Morandi,et al.  Nanoparticle‐induced platelet aggregation and vascular thrombosis , 2005, British journal of pharmacology.

[60]  Robert B Sim,et al.  Complement activation by carbon nanotubes. , 2011, Advanced drug delivery reviews.

[61]  Malcolm L. H. Green,et al.  Effects of covalent functionalization on the biocompatibility characteristics of multi-walled carbon nanotubes. , 2008, Journal of nanoscience and nanotechnology.

[62]  Martinus Løvik,et al.  Single-walled and multi-walled carbon nanotubes promote allergic immune responses in mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[63]  Bengt Fadeel,et al.  Single-walled carbon nanotubes impair human macrophage engulfment of apoptotic cell corpses , 2009, Inhalation toxicology.

[64]  R. Klaper,et al.  Functionalization impacts the effects of carbon nanotubes on the immune system of rainbow trout, Oncorhynchus mykiss. , 2010, Aquatic toxicology.